Barry, Ian Patrick
Macarulay, Reane
Brodmann, Marianne
Zeller, Thomas
Moscovic, Matej
Dahm, Johannes
Troisi, Nicola
Tepe, Gunnar
Wong, Jacqueline
Mwipatayi, Bibombe Patrice http://orcid.org/0000-0003-1977-0382
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
BIOLUX P-III Passeo-18 Lux All-Comers Registry: 24-Month Results in Below-the-Knee Arteries
https://doi.org/10.1007/s00270-020-02586-3
Sex-Related Outcomes Following Drug Balloon Angioplasty in Patients from the BIOLUX P-III Registry: A Subgroup Analysis
https://doi.org/10.1007/s00270-022-03135-w
Funding for this research was provided by:
Biotronik
University of Western Australia
Article History
Received: 27 January 2022
Accepted: 23 March 2022
First Online: 20 April 2022
Declarations
:
: Bibombe P Mwipatayi is a consultant with Medtronic, Getinge, Boston Scientific, and Biotronik and receives honoraria and research grants from Getinge, BD BARD, and Biotronik. Thomas Zeller (1) received honoraria from Abbott Vascular, Veryan, Biotronik, Boston Scientific Corp., Cook Medical, Gore & Associates, Medtronic, Philips-Spectranetics, Shockwave, and BIBA Medical; (2) consulted for Boston Scientific Corp., Gore & Associates, Medtronic, Veryan, Intact Vascular, Shockwave, Bayer, and Vesper Medical; (3) received research, clinical trial, or drug study funds from 480 biomedical, Bard Peripheral Vascular, Veryan, Biotronik, Cook Medical, Gore & Associates, Medtronic, Philips, Terumo, TriReme, Shockwave, Med Alliance, Intact Vascular, and B. Braun; and (4) has common stock in QT Medical. Marianne Brodmann (1) received honoraria from Abbott Vascular, Biotronik, Boston Scientific Corp., Cook Medical, Medtronic, Philips-Spectranetics, Shockwave, and BD Bard and (2) consulted for Abbott Vascular, Biotronik, Boston Scientific Corp., Cook Medical, Medtronic, Philips-Spectranetics, Shockwave, BD Bard, Reflow Medical, Cagent, MedAlliance, Intact Vascular, and Bolt Medical. Gunnar Tepe received research, clinical trial, or drug study funds from Bayer Health Care, BBraun, Boston Scientific, BARD, Biotronic, Gore, Medtronic, Philips, and Shockwave. The other authors have no conflict of interest to declare.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: For this type of study, consent for publication is not required.